- Case Report
Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria
- Anna Angelousi,
- Dimitrios C. Ziogas,
- Vasiliki Siampanopoulou,
- Chrysoula Mytareli,
- Amalia Anastasopoulou,
- George Lyrarakis and
- Helen Gogas
Background: Checkpoint inhibitor (CPI)-associated diabetes mellitus (CPI-DM) is a rare immune-related adverse event (irAE) that presents with variable clinical manifestations. Data about its pathogenesis have not yet been adequately studied. Methods:...

